CLINICAL_TRIALS trial_result · 2024-08-06

Clinical Trial Update: Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis [Phase 2]

A Phase 2 clinical trial evaluating VLY-686 for relieving symptoms of gastroparesis has completed and posted results as of August 6, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Vanda Pharmaceuticals | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2024-08-06